Add BrightSurf on Google Email

Study suggests potential new approach to glaucoma therapy

Researchers at Washington University School of Medicine have identified a potential new approach to treating glaucoma by inhibiting an enzyme that produces excessive nitric oxide, leading to cell damage. The study found that rats with elevated eye pressure lost less than 10% of their retinal ganglion cells when treated with the inhibitor.

SourceWashU Medicine·JournalProceedings of the National Academy of Sciences·DateAug 17, 1999

Congenital Glaucoma Gene Discovered

A groundbreaking study has identified a gene responsible for primary congenital glaucoma, a condition affecting 1 in 2,000 to 1 in 10,000 births. The discovery holds promise for early diagnosis and treatment, potentially preventing blindness, with the potential to be applied to adult-onset primary open angle glaucoma.